Table 3.
P4 | P8 | P16 | ||||
---|---|---|---|---|---|---|
| ||||||
n | controls 10 | double transgenic 9 | controls 8 | double transgenic 8 | controls 14 | double transgenic 8 |
VL (cm3) | 0.135 ± 0.009 | 0.152 ± 0.010 | 0.249 ± 0.014 | 0.271 ± 0.017 | 0.376 ± 0.015 | 0.392 ± 0.027 |
Sva (cm2/cm3) | 294 ± 12 | 277 ± 10 | 340 ± 18 | 293 ± 17 | 361 ± 12 | 358 ± 17 |
Vvp (%) | 0.964 ± 0.007 | 0.986 ± 0.019 | 0.989 ± 0.002 | 0.992 ± 0.002 | 0.995 ± 0.001 | 0.992 ± 0.002 |
MLI (μm) | 13.8 ± 0.5 | 14.6 ± 0.5 | 12.0 ± 0.7 | 14.0 ± 0.8 | 11.3 ± 0.4 | 11.3 ± 0.5 |
Sa (cm2) | 38 ± 3 | 41 ± 2 | 83 ± 6 | 79 ± 7 | 135 ± 7 | 139 ± 10 |
Treatment with doxycycline was the same as that for animals used for microarray analysis. Pups were collected from 3 or 4 litters per stage at postnatal days 4, 8 or 16. Data are mean ± SE. Abbreviations: n, number of individuals per group; VL, lung volume; Sva, alveolar surface density; Vvp, volumetric density of lung alveolar parenchyma; MLI, mean linear intercept; Sa, absolute surface area of airspaces. No significant difference was observed between the 2 groups for any parameter either at P4, P8 or P16 (two-tailed t-test).